Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 1756 for

Edit search filters
  1. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma

    Scottsdale/Phoenix, AZ

  2. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

    Rochester, MN

  3. A Safety And Efficacy Study Of Treatment Combinations With And Without Chemotherapy In Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Niraparib + TSR042 In BRCA Mutated Breast Cancer

    Rochester, MN

  5. Study Of ORIC-533 In Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  6. Study Of Ociperlimab In Combination With Tislelizumab In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Breast Cancer, Reasoning, And Activity Intervention

    Scottsdale/Phoenix, AZ

  8. A Study To Evaluate The Surgical Removal Of Residual Brain Tumors Prior To Recurrence

    Rochester, MN

  9. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP In Newly Diagnosed High-intermediate And High Risk DLBCL Patients

    Jacksonville, FL, Rochester, MN

  10. A Dose-Escalation And Expansion Study Of BGB-16673 In Participants With B-Cell Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer